全文获取类型
收费全文 | 10847篇 |
免费 | 1032篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 188篇 |
儿科学 | 352篇 |
妇产科学 | 422篇 |
基础医学 | 1381篇 |
口腔科学 | 181篇 |
临床医学 | 1136篇 |
内科学 | 1972篇 |
皮肤病学 | 148篇 |
神经病学 | 1314篇 |
特种医学 | 288篇 |
外科学 | 1241篇 |
综合类 | 335篇 |
一般理论 | 6篇 |
预防医学 | 1159篇 |
眼科学 | 141篇 |
药学 | 958篇 |
中国医学 | 13篇 |
肿瘤学 | 657篇 |
出版年
2022年 | 78篇 |
2021年 | 171篇 |
2020年 | 120篇 |
2019年 | 165篇 |
2018年 | 181篇 |
2017年 | 173篇 |
2016年 | 189篇 |
2015年 | 185篇 |
2014年 | 298篇 |
2013年 | 380篇 |
2012年 | 547篇 |
2011年 | 570篇 |
2010年 | 296篇 |
2009年 | 238篇 |
2008年 | 494篇 |
2007年 | 478篇 |
2006年 | 456篇 |
2005年 | 454篇 |
2004年 | 426篇 |
2003年 | 409篇 |
2002年 | 409篇 |
2001年 | 366篇 |
2000年 | 387篇 |
1999年 | 328篇 |
1998年 | 120篇 |
1997年 | 124篇 |
1996年 | 111篇 |
1995年 | 99篇 |
1994年 | 91篇 |
1993年 | 85篇 |
1992年 | 212篇 |
1991年 | 229篇 |
1990年 | 261篇 |
1989年 | 208篇 |
1988年 | 187篇 |
1987年 | 202篇 |
1986年 | 179篇 |
1985年 | 210篇 |
1984年 | 154篇 |
1983年 | 108篇 |
1982年 | 75篇 |
1980年 | 69篇 |
1979年 | 111篇 |
1978年 | 100篇 |
1976年 | 69篇 |
1975年 | 74篇 |
1974年 | 103篇 |
1973年 | 89篇 |
1972年 | 86篇 |
1971年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
81.
82.
Brown JJ Thomson W Clegg P Eyre S Kennedy LJ Matthews J Carter S Ollier WE 《Tissue antigens》2004,64(2):173-179
The full extent of the polymorphism of ELA-DRA in Equidae is not yet known. Given the apparent differences in DRA polymorphisms between Equidae and other species, the aims of this study were to more fully characterize ELA-DRA, determine the extent of gene polymorphism and establish the allele-frequency distribution. An allele reference panel for the second exon of ELA-DRA was established by sequence-based typing of 69 equine DNA samples consisting of various breeds of domestic horse (Equus caballus), together with donkeys (Equus asinus), Grant's zebras (Equus boehmi) and one onager (Equus hemionus). Five of the six previously reported alleles detected using single-strand conformation polymorphism were found: ELA-DRA*0101, ELA-DRA*0201, ELA-DRA*0301, ELA-DRA*0501 (Albright-Fraser DG et al. Polymorphism of DRA among equids. Immunogenetics 1996: 43: 315-7) and ELA-DRA*0601 (GenBank accession number AF5419361). In addition to the previously reported alleles, five novel ELA-DRA alleles were detected within the ELA-DRA allele reference panel. One of these was identified in E. caballus (ELA-DRA*JBH11), one in E. boehmi and E. hemionus (ELA-DRA*JBZ185) and three in E. asinus (ELA-DRA*JBD3, ELA-DRA*JBD17 and ELA-DRA*JBH45). A total of 565 equine DNA samples were screened using reference-strand-mediated conformation analysis, a double-stranded conformation-based mutation detection system that can be used to type existing ELA-DRA alleles and identify new variants. Based on our findings, at least 11 ELA-DRA alleles are now known to exist, and this level of polymorphism at the DRA locus appears to be unique to the genus Equus. Both the previously reported alleles and the new alleles displayed a species-specific distribution. 相似文献
83.
84.
A delayed hypersensitivity (DH) reaction is induced by a sensitizing intradermal injection of methylated bovine serum albumin (MBSA) into the abdomen of mice and a subsequent challenge injection of MBSA into the hind paw. Paw volume increase is measured by mercury plethysmography. The conditions for sensitization have been investigated. Sensitization with a 0.25% MBSA emulsion resulted in a small but significant swelling of the paw following the challenge injection. The magnitude of the footpad response to the challenge injection was increased if the antigen administered in the sensitizing injection was emulsified with Freund's incomplete adjuvant. Incorporation ofMycobacterium butyricum in the emulsion greatly increased the footpad response if added at doses of 0.05 and 1 mg per animal. A higher dose (4 mg), however, resulted in a lower response. The time course of development of the delayed hypersensitivity reaction has been studied. An 8-day interval between sensitization and challenge resulted in a greater delayed hypersensitivity response than a shorter (3-day) or longer (15-, 21-, 28-day) interval. Cyclophosphamide (250 mg kg–1) administered 3 days prior to the sensitizing injection of MBSA produced a modest enhancement of the DH reaction.On the basis of these studies a protocol for conducting the DH reaction to MBSA was established and the activity of drugs on processes underlying the sensitization phase of the reaction or processes underlying the elicitation phase of the reaction have been examined. Steroid and immunosuppressant drugs were found to inhibit the DH footpad response when dosed during the sensitization whereas several specific-anti-rheumatic and immunoactive compounds were without effect. Indomethacin and sudoxicam inhibited the DH reaction if dosed during the elicitation of the reaction but other non-steroidal anti-inflammatories tested did not significantly reduce the response. The clinically used anti-rheumatic drugsd-penicillamine and levamisole did not inhibit the elicitation phase of the DH response but niridazole at 100 mg kg–1 did reduce the inflammatory response.This paper has been presented in part as a poster presentation to the British Pharmacological Society, 4–6 January 1978. 相似文献
85.
Yu Feng Karen G Wigg Rohit Makkar Abel Ickowicz Tejaswee Pathare Rosemary Tannock Wendy Roberts Molly Malone James L Kennedy Russell Schachar Cathy L Barr 《American journal of medical genetics. Part B, Neuropsychiatric genetics》2005,(1):1-6
The dopamine transporter gene (DAT1) has been reported to be associated with attention-deficit hyperactivity disorder (ADHD) in a number of studies [Cook et al. (1995): Am J Human Genet 56(4):9993-998; Gill et al. (1997): Mol Psychiatry 2(4):311-313; Waldman et al. (1998): Am J Human Genet 63(6):1767-1776; Barr et al. (2001): Biol Psychiatry 49(4):333-339; Curran et al. (2001): Mol Psychiatry 6(4):425-428; Chen et al. (2003): Mol Psychiatry 8(4):393-396]. Specifically, the 10-repeat allele of the 40-bp variable number of tandem repeats (VNTR) polymorphism located in the 3' untranslated region (UTR) of the gene has been found to be associated with ADHD. There is evidence from in vitro studies indicating that variability in the repeat number, and sequence variation in the 3'-UTR of the DAT1 gene may influence the level of the dopamine transporter protein [Fuke et al. (2001): Pharmacogenomics J 1(2):152-156; Miller and Madras (2002): Mol Psychiatry 7(1):44-55]. In this study, we investigated whether DNA variation in the DAT1 3'UTR contributed to ADHD by genotyping DNA variants around the VNTR region in a sample of 178 ADHD families. These included a MspI polymorphism (rs27072), a DraI DNA change (T/C) reported to influence DAT1 expression levels, and a BstUI polymorphism (rs3863145) in addition to the VNTR. We also screened the VNTR region by direct resequencing to determine if there was sequence variation within the repeat units that could account for the association. Our results indicate that DAT1 is associated with ADHD in our sample but not with alleles of the VNTR polymorphism. We did not find any variation in the sequence for either the 10- or 9-repeat alleles in the probands screened nor did we observe the reported DraI (T/C) variation. Our results therefore refute the possibility of the reported DraI variation or alleles of the VNTR as the functional variants contributing to the disorder. 相似文献
86.
Shinkai T De Luca V Zai G Shaikh S Matsumoto C Arnold PD Hwang R King N Trakalo J Potapova N Wong G Hori H Wong AH Ohmori O Nakamura J Kennedy JL 《Psychiatric genetics》2004,14(3):177-180
OBJECTIVE: Oxidative stress such as free radical-mediated neuronal dysfunction may be involved in the pathophysiology of schizophrenia. The human glutathione peroxidase (GPX1) is a selenium-dependent enzyme, which plays an important role in the detoxification of free radicals. We therefore hypothesized that the GPX1 gene, which is located on chromosome 3p21.3, may be involved in the pathophysiology of schizophrenia. The aim of this study is to examine whether a potentially functional polymorphism, a proline (Pro) to leucine (Leu) substitution at codon 197 (Pro197Leu) of the human GPX1 gene, is associated with susceptibility to schizophrenia. METHODS: We genotyped the Pro197Leu polymorphism in a total of 113 nuclear families that had a proband with schizophrenia. Genetic association was tested using the transmission disequilibrium test (TDT), the sib transmission disequilibrium test (STDT), and the family-based association test (FBAT). RESULTS: The minor allele (Leu) frequency was calculated to be 0.282. We could not find significant transmission disequilibrium of the alleles for the Pro197Leu polymorphism in the GPX1 gene in association with the presence of schizophrenia in our family sample (TDT, chi2=0.03, degrees of freedom=1, P=0.86; combined TDT-STDT, Z'=-0.052, P=0.47; FBAT, Z=0.000, P=1.000). CONCLUSION: The results of this study suggest that the GPX1 polymorphism is unlikely to be associated with susceptibility to schizophrenia. 相似文献
87.
James L. Kennedy Elizabeth A. Billett Fabio M. Macciardi Massimiliano Verga Thomas J. Parsons Herbert Y. Meltzer Jeffery Lieberman Janet A. Buchanan 《American journal of medical genetics. Part A》1995,60(6):558-562
Several groups have reported an association between schizophrenia and the MscI polymorphism in the first exon of the dopamine D3 receptor gene (DRD3). We studied this polymorphism using a North American sample (117 patients plus 188 controls) and an Italian sample (97 patients plus 64 controls). In the first part of the study, we compared allele frequencies of schizophrenia patients and unmatched controls and observed a significant difference in the total sample (P = 0.01). The second part of the study involved a case control approach in which each schizophrenia patient was matched to a control of the same sex, and of similar age and ethnic background. The DRD3 allele frequencies of patients and controls revealed no significant difference between the two groups in the Italian (N = 53) or the North American (N = 54) matched populations; however, when these two matched samples were combined, a significant difference was observed (P = 0.026). Our results suggest that the MscI polymorphism may be associated with schizophrenia in the populations studied. © 1995 Wiley-Liss, Inc. 相似文献
88.
89.
Pato CN Macedo A Ambrosio A Vincent JB Bauer A Schindler K Xu J Coelho I Dourado A Valente J Azevedo MH Kennedy JL Pato MT 《American journal of medical genetics》2000,96(6):854-857
We have studied 24 families with multiple affected members with bipolar disorder to test the hypothesis that in those families clinically showing genetic anticipation [Macedo et al., 1999] we would find large repeat expansions. The families meeting inclusion criteria had a minimum of two affected members over two generations and showed marked anticipation both in terms of age of onset and disease severity. We used the repeat expansion detection (RED) method to test patients (n = 24) and controls from these families and unrelated controls (n = 53). We also genotyped patients and family members from two families with large expansions at the known expansion loci on chromosomes 13, 17, and 18. The RED method revealed a higher number of large expansions in patients compared with controls (t-test; P < 0.0055: Mann-Whitney U; P = 0.02). The patients with the largest expansions were typed at the specific loci on chromosomes 13, 17, and 18 and the chromosome 18 expansion locus segregated with disease in one family, and a second family showed segregation with the expansion located at the SCA8 locus on chromosome 13. Genetic anticipation had been analyzed in this cohort of families, with correction for potential ascertainment bias, possible proband effects, cohort effects, regression to the mean, gender effects, and maternal vs. paternal transmission. None of these potential confounds appeared to account for the observed anticipation. We also identified that the presence of large expansions in affected family members derives primarily from two families from the genetically isolated Azores population. One family shows segregation with the chromosome 18 locus, whereas the other family segregates with expansions at the SCA8 locus. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 96:854-857, 2000. 相似文献
90.
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response 总被引:5,自引:0,他引:5 下载免费PDF全文
Kennedy MC Wang J Zhang Y Miles AP Chitsaz F Saul A Long CA Miller LH Stowers AW 《Infection and immunity》2002,70(12):6948-6960
Apical membrane antigen 1 (AMA1) is regarded as a leading malaria blood-stage vaccine candidate. While the overall structure of AMA1 is conserved in Plasmodium spp., numerous AMA1 allelic variants of P. falciparum have been described. The effect of AMA1 allelic diversity on the ability of a recombinant AMA1 vaccine to protect against human infection by different P. falciparum strains is unknown. We characterize two allelic forms of AMA1 that were both produced in Pichia pastoris at a sufficient economy of scale to be usable for clinical vaccine studies. Both proteins were used to immunize rabbits, singly and in combination, in order to evaluate their immunogenicity and the ability of elicited antibodies to block the growth of different P. falciparum clones. Both antigens, when used alone, elicited high homologous anti-AMA1 titers, with reduced strain cross-reactivity. Similarly, sera from rabbits immunized with a single antigen were capable of blocking the growth of homologous parasite strains at levels theoretically sufficient to clear parasite infections. However, heterologous inhibition was significantly reduced, providing experimental evidence that AMA1 allelic diversity is a result of immune pressure. Encouragingly, rabbits immunized with a combination of both antigens exhibited titers and levels of parasite inhibition as good as those of the single-antigen-immunized rabbits for each of the homologous parasite lines, and consequently exhibited a broadening of allelic diversity coverage. 相似文献